Facial injectables, are also called as facial fillers, and are used in aesthetic therapeutic procedures to enhance facial appearance. Facial injectables are used for smoothening wrinkles and scars on the face by filling the target area. Dermal fillers reduce wrinkles and add volume to the cheeks and lips and are injected directly in the wrinkles, while anti-wrinkle injections relax the muscles that cause creases. Facial injectable are mostly used for treating early signs of aging and increasing the aesthetic beauty. Some of the most commonly used facial injectables are collagens, hyaluronic acids, polymers, and botulinum toxin.
Market Dynamics
Increasing demand for non-surgical procedures for facial rejuvenation and correction is expected to augment the facial injectables market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS): 2017, surgical and non-surgical cosmetic procedures exhibited an overall increase of 9% from 2016 to 2017. Furthermore, according to the British Association of Aesthetic Plastic Surgeons, in 2013, anti-ageing facelifts and brow lifts cosmetic operations exhibited a 17% rise compared to 2012 across the globe, signifying an increase in acceptance of facial injectables.
However, adverse effects of dermal fillers include hypersensitivity reactions such as swelling, erythema, and tenderness within a few minutes of injection, granuloma formation, vascular occlusions, biofilms formation, bruising, discoloration, and rashes is expected to hinder growth of the facial injectables market during the forecast period.
Key features of the study:
- This report provides in-depth analysis of the facial injectables market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2027, considering 2018 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global facial injectables market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
- Key players covered as part of this study include Allergan plc, Galderma S.A., Medytox Inc., SciVision Biotech Inc., Croma-Pharma GmbH, Anika Therapeutics, Inc., Merz Pharmaceuticals, Sinclair Pharma plc, Suneva Medical, Inc. and Zimmer MedizinSysteme GmbH
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global facial injectables market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for facial injectables market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Facial injectables Market, By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- Global Facial injectables Market, By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- Global Facial injectables Market, By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Global Facial injectables Market, By Region:
- North America
- By Country:
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- Dermal Fillers
- Hyaluronic Acid Fillers
- Collagen Fillers
- Synthetic Fillers
- Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-lactic acid (PLLA)
- By Application:
- Wrinkle Reduction
- Facelift
- Lip Enhancement
- Others
- By End User:
- Hospitals
- Beauty Clinics
- Dermatology Centers
- Company Profiles
- Allergan plc*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Galderma S.A.
- Medytox Inc.
- SciVision Biotech Inc.
- Croma-Pharma GmbH
- Anika Therapeutics, Inc.
- Merz Pharmaceuticals
- Sinclair Pharma plc
- Suneva Medical, Inc.
- Zimmer MedizinSysteme GmbH
“*” marked represents similar segmentation in other categories in the respective section
